Panafil

Panafil

a trademark for a fixed-combination topical drug containing an enzyme (papain).
References in periodicals archive ?
Prior authorization for ACCUZYME and PANAFIL is not required.
ACCUZYME Ointment, Papain, Urea, 30 gram tube (NDC# 00064-1000-01) and PANAFIL Ointment, Papain, Urea, Chlorophyllin Copper Complex Sodium, 30 gram tube (NDC# 00064-3410-30) are readily available at pharmacies and drug wholesalers in California and nationwide.
ACCUZYME SE and PANAFIL SE are the first wound care treatments to receive this commendation from the Arthritis Foundation.
The new spray emulsion for ACCUZYME and PANAFIL represent a significant advance in wound care treatment," said Sarah Young, Product Manager at HEALTHPOINT.
According to HEALTHPOINT, the suit against Stratus was instituted when the company learned that patients were being prescribed Accuzyme and Panafil, yet Kovia and Ziox were substituted without a determination that the substituted products were pharmaceutically equivalent, therapeutically equivalent or bioequivalent.
Upon the acquisition of PANAFIL from Integra Life Sciences in 1998, HEALTHPOINT began emphasizing in its marketing approach the healing properties the product's chlorophyllin copper complex sodium provides to granulating wounds in conjunction with its proteolytic enzyme.
After the launch of PANAFIL Spray earlier this year, clinicians across the country began asking for the same delivery form for ACCUZYME Ointment," said Dwayne Dixon, director of marketing for wound preparation and healing at HEALTHPOINT.
Sturza shows complete ignorance of the products he himself cites as competition by referring to Panafil as a wound healing agent.
When the company contacted the New York State Department of Health to interpret the program with relation to their two brands Accuzyme and Panafil, an official stated that the program would not affect either product based on the criteria that New York State is using.
Products include Iodosorb(R), Accuzyme(R), Panafil, Cloderm(R), and Proshield Plus(R).
In particular, the Court determined that it is likely that HEALTHPOINT will succeed in showing that Stratus' use of terms and phrases like "generic," "generic alternative," "branded generic," "bioequivalent," or "equivalent" improperly suggest that Kovia is interchangeable with Accuzyme and Ziox is interchangeable with Panafil since there has been no determination of these products' equivalence.
Rystan's Panafil product line is an excellent fit with Integra's business of providing unique and innovative products for burns and skin defects, including INTEGRA(R) Artificial Skin.